Resende, R., Ferreiro, E., Pereira, C
Science 305:14661470 Wang Y, Guo D, He J, Song L, Chen H, Zhang Z, Tan N (2019) Inhibition of fatty acid synthesis arrests colorectal neoplasm growth and metastasis: anti-cancer therapeutical effects of natural cyclopeptide RA-XII
Contraindications include active malignancy, uncontrolled diabetes, pregnancy, or history of certain cancers
10.1016/j.jns.2009.10.023 41 CappelliniM
Our results suggest that the significance of estimated pooled effect size is not biased by any single study
Loading Phase (Weeks 1 through 4) Tb-500: 2 to 2.5 mg twice weekly (Monday and Thursday) totaling 4 to 5 mg per week Bpc-157: 0.5 mg daily, either as single dose or split into 0.25 mg twice daily Maintenance Phase (Weeks 5 through 8 plus) Tb-500: 2 mg once weekly Bpc-157: 0.25 to 0.5 mg daily Critical Notes Use separate vials and syringes for each peptide Never mix Bpc-157 and Tb-500 in the same syringe Tb-500 can be injected anywhere subcutaneously Bpc-157 should ideally be injected near the injury site The critical implementation detail bears repeating: Bpc-157 and Tb-500 should never be combined into a single vial as peptides lose their effectiveness when mixed incorrectly
